Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Obstructive Lung Diseases

  Free Subscription


Articles published in Respir Med

Retrieve available abstracts of 185 articles:
HTML format
Text format



Single Articles


    March 2019
  1. FARAH CS, Badal T, Reed N, Rogers PG, et al
    Mepolizumab improves small airway function in severe eosinophilic asthma.
    Respir Med. 2019;148:49-53.
    PubMed     Text format     Abstract available


  2. SASSO F, Izard M, Beneteau T, Rakotozandry T, et al
    18-year evolution of asthma and allergic diseases in French urban schoolchildren in relation to indoor air pollutant levels.
    Respir Med. 2019;148:31-36.
    PubMed     Text format     Abstract available


  3. FERRI S, Crimi C, Heffler E, Campisi R, et al
    Vitamin D and disease severity in bronchiectasis.
    Respir Med. 2019;148:1-5.
    PubMed     Text format     Abstract available


  4. KURUVILLA ME, Vanijcharoenkarn K, Shih JA, Lee FE, et al
    Epidemiology and risk factors for asthma.
    Respir Med. 2019;149:16-22.
    PubMed     Text format    


    February 2019
  5. KOSSE RC, Bouvy ML, de Vries TW, Koster ES, et al
    Effect of a mHealth intervention on adherence in adolescents with asthma: A randomized controlled trial.
    Respir Med. 2019 Feb 16. pii: S0954-6111(19)30045.
    PubMed     Text format     Abstract available


  6. JEMINIWA R, Hohmann L, Qian J, Garza K, et al
    Impact of eHealth on medication adherence among patients with asthma: A systematic review and meta-analysis.
    Respir Med. 2019 Feb 15. pii: S0954-6111(19)30047.
    PubMed     Text format     Abstract available


  7. TAPONEN S, Uitti J, Karvala K, Luukkonen R, et al
    Asthma diagnosed in late adulthood is linked to work disability and poor employment status.
    Respir Med. 2019;147:76-78.
    PubMed     Text format     Abstract available


  8. CIOLKOWSKI J, Emeryk A, Hydzik P, Emeryk-Maksymiuk J, et al
    Eosinophilic airway inflammation is a main feature of unstable asthma in adolescents.
    Respir Med. 2019;147:7-12.
    PubMed     Text format     Abstract available


  9. BJERMER L, Eriksson G, Radner F, Peterson S, et al
    Time to onset of improvements in Quality of Life from Temperature-controlled Laminar Airflow (TLA) in severe allergic asthma.
    Respir Med. 2019;147:19-25.
    PubMed     Text format     Abstract available


    January 2019
  10. KATSOULIS K, Ismailos G, Kipourou M, Kostikas K, et al
    Microbiota and asthma: Clinical implications.
    Respir Med. 2019;146:28-35.
    PubMed     Text format    


  11. ALSUMRAIN M, De Giacomi F, Nasim F, Koo CW, et al
    Combined pulmonary fibrosis and emphysema as a clinicoradiologic entity: Characterization of presenting lung fibrosis and implications for survival.
    Respir Med. 2019;146:106-112.
    PubMed     Text format     Abstract available


  12. BALDACCI S, Simoni M, Maio S, Angino A, et al
    Prescriptive adherence to GINA guidelines and asthma control: An Italian cross sectional study in general practice.
    Respir Med. 2019;146:10-17.
    PubMed     Text format     Abstract available


    December 2018
  13. LIMA-MATOS A, Ponte EV, de Jesus JPV, Almeida PCA, et al
    Eosinophilic asthma, according to a blood eosinophil criterion, is associated with disease severity and lack of control among underprivileged urban Brazilians.
    Respir Med. 2018;145:95-100.
    PubMed     Text format     Abstract available


  14. MATTHES S, Stadler J, Barton J, Leuschner G, et al
    Asthma features in severe COPD: Identifying treatable traits.
    Respir Med. 2018;145:89-94.
    PubMed     Text format     Abstract available


  15. ZENG J, Chen Z, Hu Y, Hu Q, et al
    Asthma control in preschool children with small airway function as measured by IOS and fractional exhaled nitric oxide.
    Respir Med. 2018;145:8-13.
    PubMed     Text format     Abstract available


  16. BALTIERI L, Cazzo E, de Souza AL, Alegre SM, et al
    Influence of weight loss on pulmonary function and levels of adipokines among asthmatic individuals with obesity: One-year follow-up.
    Respir Med. 2018;145:48-56.
    PubMed     Text format     Abstract available


  17. VON BULOW A, Backer V, Bodtger U, Soes-Petersen NU, et al
    Differentiation of adult severe asthma from difficult-to-treat asthma - Outcomes of a systematic assessment protocol.
    Respir Med. 2018;145:41-47.
    PubMed     Text format     Abstract available


  18. HOSSEINI SA, Zilaee M, Shoushtari MH, Ghasemi Dehcheshmeh M, et al
    An evaluation of the effect of saffron supplementation on the antibody titer to heat-shock protein (HSP) 70, hsCRP and spirometry test in patients with mild and moderate persistent allergic asthma: A triple-blind, randomized placebo-controlled trial.
    Respir Med. 2018;145:28-34.
    PubMed     Text format     Abstract available


  19. PEREIRA AA, Pollard SL, Locke R, Romero K, et al
    Association between exhaled carbon monoxide and asthma outcomes in Peruvian children.
    Respir Med. 2018;145:212-216.
    PubMed     Text format     Abstract available


  20. AJALA O, Zhang Y, Gupta A, Bon J, et al
    Decreased serum TRAIL is associated with increased mortality in smokers with comorbid emphysema and coronary artery disease.
    Respir Med. 2018;145:21-27.
    PubMed     Text format     Abstract available


  21. O'NEILL K, Lakshmipathy GR, Ferguson K, Cosgrove D, et al
    Quality control for multiple breath washout tests in multicentre bronchiectasis studies: Experiences from the BRONCH-UK clinimetrics study.
    Respir Med. 2018;145:206-211.
    PubMed     Text format     Abstract available


  22. RADOVANOVIC D, Santus P, Blasi F, Sotgiu G, et al
    A comprehensive approach to lung function in bronchiectasis.
    Respir Med. 2018;145:120-129.
    PubMed     Text format     Abstract available


  23. MAO S, Wu L, Shi W
    Association between trace elements levels and asthma susceptibility.
    Respir Med. 2018;145:110-119.
    PubMed     Text format     Abstract available


    November 2018
  24. NGUYEN TS, Nguyen TLH, Pham TTV, Cao TBT, et al
    Effectiveness of a short training program for community pharmacists to improve knowledge and practice of asthma counselling - A simulated patient study.
    Respir Med. 2018;144:50-60.
    PubMed     Text format     Abstract available


  25. NORDON C, Grimaldi-Bensouda L, Pribil C, Nachbaur G, et al
    Clinical and economic burden of severe asthma: A French cohort study.
    Respir Med. 2018;144:42-49.
    PubMed     Text format     Abstract available


  26. JEPPEGAARD M, Veidal S, Sverrild A, Backer V, et al
    Validation of ATS clinical practice guideline cut-points for FeNO in asthma.
    Respir Med. 2018;144:22-29.
    PubMed     Text format     Abstract available


    October 2018
  27. BUHL R, FitzGerald JM, Busse WW
    Tiotropium add-on to inhaled corticosteroids versus addition of long-acting beta2-agonists for adults with asthma.
    Respir Med. 2018;143:82-90.
    PubMed     Text format     Abstract available


  28. MANSUR AH, Srivastava S, Sahal A
    Disconnect of type 2 biomarkers in severe asthma; dominated by FeNO as a predictor of exacerbations and periostin as predictor of reduced lung function.
    Respir Med. 2018;143:31-38.
    PubMed     Text format     Abstract available


  29. DAVIES SE, Bishopp A, Wharton S, Turner AM, et al
    Does Continuous Positive Airway Pressure (CPAP) treatment of obstructive sleep apnoea (OSA) improve asthma-related clinical outcomes in patients with co-existing conditions?- A systematic review.
    Respir Med. 2018;143:18-30.
    PubMed     Text format     Abstract available


  30. SCHUERMANS D, Hanon S, Wauters I, Verbanck S, et al
    Impact of a single 10 min education session on asthma control as measured by ACT.
    Respir Med. 2018;143:14-17.
    PubMed     Text format     Abstract available


  31. XIN L, Gao J, Ge X, Tian C, et al
    Increased pro-inflammatory cytokine-secreting regulatory T cells are correlated with the plasticity of T helper cell differentiation and reflect disease status in asthma.
    Respir Med. 2018;143:129-138.
    PubMed     Text format     Abstract available


  32. BIANCHI L, Bezzi M, Berlendis M, Marino S, et al
    Additive effect on pulmonary function and disability of intensive pulmonary rehabilitation following bronchoscopy lung volume reduction (BLVR) for severe emphysema.
    Respir Med. 2018;143:116-122.
    PubMed     Text format     Abstract available


  33. ALMOMANI BA, Mokhemer E, Al-Sawalha NA, Momany SM, et al
    A novel approach of using educational pharmaceutical pictogram for improving inhaler techniques in patients with asthma.
    Respir Med. 2018;143:103-108.
    PubMed     Text format     Abstract available


    September 2018
  34. MUNESWARAO J, Hassali MA, Verma AK
    Comment on "A novel approach of using educational pharmaceutical pictogram for improving inhaler techniques in patients with asthma".
    Respir Med. 2018 Sep 19. pii: S0954-6111(18)30294.
    PubMed     Text format    


  35. BERTI A, Volcheck GW, Cornec D, Smyth RJ, et al
    Severe/uncontrolled asthma and overall survival in atopic patients with eosinophilic granulomatosis with polyangiitis.
    Respir Med. 2018;142:66-72.
    PubMed     Text format     Abstract available


  36. HEFFLER E, Crimi C, Mancuso S, Campisi R, et al
    Misdiagnosis of asthma and COPD and underuse of spirometry in primary care unselected patients.
    Respir Med. 2018;142:48-52.
    PubMed     Text format     Abstract available


  37. CAVALLAZZI R, Jorayeva A, Beatty BL, Antimisiaris D, et al
    Predicting asthma in older adults on the basis of clinical history.
    Respir Med. 2018;142:36-40.
    PubMed     Text format     Abstract available


  38. PELKONEN MK, Notkola IK, Laatikainen TK, Jousilahti P, et al
    30-year trends in asthma and the trends in relation to hospitalization and mortality.
    Respir Med. 2018;142:29-35.
    PubMed     Text format     Abstract available


  39. PAPAIOANNOU AI, Diamant Z, Bakakos P, Loukides S, et al
    Towards precision medicine in severe asthma: Treatment algorithms based on treatable traits.
    Respir Med. 2018;142:15-22.
    PubMed     Text format     Abstract available


  40. DE BENEDETTO F, Pastorelli R, Ferrario M, de Blasio F, et al
    Supplementation with Qter((R)) and Creatine improves functional performance in COPD patients on long term oxygen therapy.
    Respir Med. 2018;142:86-93.
    PubMed     Text format     Abstract available


  41. SORIANO JB, Hahsler M, Soriano C, Martinez C, et al
    Temporal transitions in COPD severity stages within the GOLD 2017 classification system.
    Respir Med. 2018;142:81-85.
    PubMed     Text format     Abstract available


  42. BOGART M, Stanford RH, Reinsch T, Hull M, et al
    Clinical characteristics and medication patterns in patients with COPD prior to initiation of triple therapy with ICS/LAMA/LABA: A retrospective study.
    Respir Med. 2018;142:73-80.
    PubMed     Text format     Abstract available


  43. VAES AW, Spruit MA, Theunis J, Wouters EFM, et al
    Peripheral endothelial function is positively associated with maximal aerobic capacity in patients with chronic obstructive pulmonary disease.
    Respir Med. 2018;142:41-47.
    PubMed     Text format     Abstract available


    August 2018
  44. PODDIGHE D, Brambilla I, Licari A, Marseglia GL, et al
    Pediatric rhinosinusitis and asthma.
    Respir Med. 2018;141:94-99.
    PubMed     Text format     Abstract available


  45. COUMOU H, Westerhof GA, de Nijs SB, Amelink M, et al
    Diagnosing persistent blood eosinophilia in asthma with single blood eosinophil or exhaled nitric oxide level.
    Respir Med. 2018;141:81-86.
    PubMed     Text format     Abstract available


  46. BAZAN-SOCHA S, Kuczia P, Potaczek DP, Mastalerz L, et al
    Increased blood levels of cellular fibronectin in asthma: Relation to the asthma severity, inflammation, and prothrombotic blood alterations.
    Respir Med. 2018;141:64-71.
    PubMed     Text format     Abstract available


  47. ADACHI M, Kozawa M, Yoshisue H, Lee Milligan K, et al
    Real-world safety and efficacy of omalizumab in patients with severe allergic asthma: A long-term post-marketing study in Japan.
    Respir Med. 2018;141:56-63.
    PubMed     Text format     Abstract available


  48. SVEDSATER H, Jones R, Bosanquet N, Jacques L, et al
    Patient-reported outcomes with initiation of fluticasone furoate/vilanterol versus continuing usual care in the Asthma Salford Lung Study.
    Respir Med. 2018;141:198-206.
    PubMed     Text format     Abstract available


  49. LYCETT H, Wildman E, Raebel EM, Sherlock JP, et al
    Treatment perceptions in patients with asthma: Synthesis of factors influencing adherence.
    Respir Med. 2018;141:180-189.
    PubMed     Text format     Abstract available


  50. MCDONNELL MJ, O'Toole D, Ward C, Pearson JP, et al
    A qualitative synthesis of gastro-oesophageal reflux in bronchiectasis: Current understanding and future risk.
    Respir Med. 2018;141:132-143.
    PubMed     Text format     Abstract available


  51. DEVILLIER P, Humbert M, Boye A, Zachgo W, et al
    Efficacy and safety of once-daily fluticasone furoate/vilanterol (FF/VI) versus twice-daily inhaled corticosteroids/long-acting beta2-agonists (ICS/LABA) in patients with uncontrolled asthma: An open-label, randomized, controlled trial.
    Respir Med. 2018;141:111-120.
    PubMed     Text format     Abstract available


  52. SCHULER M, Wittmann M, Faller H, Schultz K, et al
    Including changes in dyspnea after inpatient rehabilitation improves prediction models of exacerbations in COPD.
    Respir Med. 2018;141:87-93.
    PubMed     Text format     Abstract available


  53. KOUIJZER M, Brusse-Keizer M, Bode C
    COPD-related fatigue: Impact on daily life and treatment opportunities from the patient's perspective.
    Respir Med. 2018;141:47-51.
    PubMed     Text format     Abstract available


  54. OHAR JA, Loh CH, Lenoir KM, Wells BJ, et al
    A comprehensive care plan that reduces readmissions after acute exacerbations of COPD.
    Respir Med. 2018;141:20-25.
    PubMed     Text format     Abstract available


  55. DOMENECH A, Munoz-Montiel A, Garcia-Casares N, Rioja J, et al
    High risk of subclinical atherosclerosis in COPD exacerbator phenotype.
    Respir Med. 2018;141:165-171.
    PubMed     Text format     Abstract available


  56. KAWAMOTO T, Kanazawa H, Tochino Y, Kawaguchi T, et al
    Evaluation of the severity of small airways obstruction and alveolar destruction in chronic obstructive pulmonary disease.
    Respir Med. 2018;141:159-164.
    PubMed     Text format     Abstract available


  57. FANER R, Noell G, Badia JR, Lopez-Giraldo A, et al
    Distribution, temporal stability and association with all-cause mortality of the 2017 GOLD groups in the ECLIPSE cohort.
    Respir Med. 2018;141:14-19.
    PubMed     Text format     Abstract available


  58. GOOD JT JR, Rollins DR, Kolakowski CA, Stevens AD, et al
    New insights in the diagnosis of chronic refractory cough.
    Respir Med. 2018;141:103-110.
    PubMed     Text format     Abstract available


  59. SCHISSLER AJ, Celli BR
    Prevalence of paradoxical bronchoconstriction after inhaled albuterol.
    Respir Med. 2018;141:100-102.
    PubMed     Text format     Abstract available


  60. SIEVI NA, Brack T, Brutsche MH, Frey M, et al
    Physical activity declines in COPD while exercise capacity remains stable: A longitudinal study over 5 years.
    Respir Med. 2018;141:1-6.
    PubMed     Text format     Abstract available


    July 2018
  61. CHEN A, Nowrouzi-Kia B, Usuba K
    Health-related quality of life in Canadians with asthma: A case-control study using census data.
    Respir Med. 2018;140:82-86.
    PubMed     Text format     Abstract available


  62. CHUNG WS, Lin CL
    Acute respiratory events in patients with bronchiectasis-COPD overlap syndrome: A population-based cohort study.
    Respir Med. 2018;140:6-10.
    PubMed     Text format     Abstract available


  63. POULSEN NN, Bjerregaard A, Khoo SK, Laing IA, et al
    Airway Interleukin-33 and type 2 cytokines in adult patients with acute asthma.
    Respir Med. 2018;140:50-56.
    PubMed     Text format     Abstract available


  64. ZHANG HP, Wang L, Wang Z, Xu XR, et al
    Chinese herbal medicine formula for acute asthma: A multi-center, randomized, double-blind, proof-of-concept trial.
    Respir Med. 2018;140:42-49.
    PubMed     Text format     Abstract available


  65. LABAKI WW, Xia M, Murray S, Curtis JL, et al
    NT-proBNP in stable COPD and future exacerbation risk: Analysis of the SPIROMICS cohort.
    Respir Med. 2018;140:87-93.
    PubMed     Text format     Abstract available


  66. WAN ES, Kantorowski A, Homsy D, Kadri R, et al
    Self-reported task-oriented physical activity: A comparison with objective daily step count in COPD.
    Respir Med. 2018;140:63-70.
    PubMed     Text format     Abstract available


  67. HENRIKSEN DP, Davidsen JR, Laursen CB
    Nationwide use of theophylline among adults-A 20-year Danish drug utilisation study.
    Respir Med. 2018;140:57-62.
    PubMed     Text format     Abstract available


  68. JUNG IY, Jeong SJ, Lee KM, Ahn JY, et al
    Risk factors for mortality in patients with Pseudomonas aeruginosa pneumonia: Clinical impact of mucA gene mutation.
    Respir Med. 2018;140:27-31.
    PubMed     Text format     Abstract available


  69. BEHROOZ L, Balekian DS, Faridi MK, Espinola JA, et al
    Prenatal and postnatal tobacco smoke exposure and risk of severe bronchiolitis during infancy.
    Respir Med. 2018;140:21-26.
    PubMed     Text format     Abstract available


  70. SIAFAKAS N, Bizymi N, Mathioudakis A, Corlateanu A, et al
    EARLY versus MILD Chronic Obstructive Pulmonary Disease (COPD).
    Respir Med. 2018;140:127-131.
    PubMed     Text format     Abstract available


  71. HYLDGAARD C, Bendstrup E, Pedersen AB, Ulrichsen SP, et al
    Increased mortality among patients with rheumatoid arthritis and COPD: A population-based study.
    Respir Med. 2018;140:101-107.
    PubMed     Text format     Abstract available


    June 2018
  72. DE ROOS EW, Lahousse L, Verhamme KMC, Braunstahl GJ, et al
    Asthma and its comorbidities in middle-aged and older adults; the Rotterdam Study.
    Respir Med. 2018;139:6-12.
    PubMed     Text format     Abstract available


  73. MUNGAN D, Aydin O, Mahboub B, Albader M, et al
    Burden of disease associated with asthma among the adult general population of five Middle Eastern countries: Results of the SNAPSHOT program.
    Respir Med. 2018;139:55-64.
    PubMed     Text format     Abstract available


  74. KERWIN E, Wachtel A, Sher L, Nyberg J, et al
    Efficacy, safety, and dose response of glycopyrronium administered by metered dose inhaler using co-suspension delivery technology in subjects with intermittent or mild-to-moderate persistent asthma: A randomized controlled trial.
    Respir Med. 2018;139:39-47.
    PubMed     Text format     Abstract available


  75. KARVALA K, Uitti J, Taponen S, Luukkonen R, et al
    Asthma trigger perceptions are associated with work disability.
    Respir Med. 2018;139:19-26.
    PubMed     Text format     Abstract available


  76. NAKAMOTO K, Saraya T, Ogawa Y, Ishii H, et al
    Comparison of findings on thoracic computed tomography with the severity and duration of bronchial asthma in patients with eosinophilic granulomatosis with polyangiitis.
    Respir Med. 2018;139:101-105.
    PubMed     Text format     Abstract available


  77. HAHN B, Hull M, Blauer-Peterson C, Buikema AR, et al
    Rates of escalation to triple COPD therapy among incident users of LAMA and LAMA/LABA.
    Respir Med. 2018;139:65-71.
    PubMed     Text format     Abstract available


  78. FERRARI R, Caram LMO, Tanni SE, Godoy I, et al
    The relationship between Vitamin D status and exacerbation in COPD patients- a literature review.
    Respir Med. 2018;139:34-38.
    PubMed     Text format     Abstract available


  79. LIU S, Zhou Y, Liu S, Zou W, et al
    Clinical impact of the lower limit of normal of FEV1/FVC on detecting chronic obstructive pulmonary disease: A follow-up study based on cross-sectional data.
    Respir Med. 2018;139:27-33.
    PubMed     Text format     Abstract available


  80. GOVE K, Wilkinson T, Jack S, Ostridge K, et al
    Systematic review of evidence for relationships between physiological and CT indices of small airways and clinical outcomes in COPD.
    Respir Med. 2018;139:117-125.
    PubMed     Text format     Abstract available


  81. DESVEAUX L, Harrison SL, Gagnon JF, Goldstein RS, et al
    Effects of exercise training on cognition in chronic obstructive pulmonary disease: A systematic review.
    Respir Med. 2018;139:110-116.
    PubMed     Text format     Abstract available


  82. LIPWORTH BJ, Jabbal S
    What can we learn about COPD from impulse oscillometry?
    Respir Med. 2018;139:106-109.
    PubMed     Text format     Abstract available


    May 2018
  83. JACOB J, Odink A, Brun AL, Macaluso C, et al
    Functional associations of pleuroparenchymal fibroelastosis and emphysema with hypersensitivity pneumonitis.
    Respir Med. 2018;138:95-101.
    PubMed     Text format     Abstract available


  84. ZAFARI Z, Sadatsafavi M, Chen W, FitzGerald JM, et al
    The projected economic and health burden of sub-optimal asthma control in Canada.
    Respir Med. 2018;138:7-12.
    PubMed     Text format     Abstract available


  85. TARRAF H, Al-Jahdali H, Al Qaseer AH, Gjurovic A, et al
    Asthma control in adults in the Middle East and North Africa: Results from the ESMAA study.
    Respir Med. 2018;138:64-73.
    PubMed     Text format     Abstract available


  86. OLUWOLE O, Rennie DC, Senthilselvan A, Dyck R, et al
    The association between endotoxin and beta-(1-->3)-D-glucan in house dust with asthma severity among schoolchildren.
    Respir Med. 2018;138:38-46.
    PubMed     Text format     Abstract available


  87. BACKMAN H, Jansson SA, Stridsman C, Muellerova H, et al
    Chronic airway obstruction in a population-based adult asthma cohort: Prevalence, incidence and prognostic factors.
    Respir Med. 2018;138:115-122.
    PubMed     Text format     Abstract available


  88. KAPPELER D, Sommerer K, Kietzig C, Huber B, et al
    Pulmonary deposition of fluticasone propionate/formoterol in healthy volunteers, asthmatics and COPD patients with a novel breath-triggered inhaler.
    Respir Med. 2018;138:107-114.
    PubMed     Text format     Abstract available


  89. MCNAMARA RJ, Houben-Wilke S, Franssen FME, Smid DE, et al
    Determinants of functional, peak and endurance exercise capacity in people with chronic obstructive pulmonary disease.
    Respir Med. 2018;138:81-87.
    PubMed     Text format     Abstract available


  90. FAKIH F, Spangenthal S, Sigal B, Darken P, et al
    Randomized study of the effects of Aerochamber Plus((R)) Flow-Vu((R)) on the efficacy, pharmacokinetics and safety of glycopyrronium/formoterol fumarate dihydrate metered dose inhaler in patients with chronic obstructive pulmonary disease.
    Respir Med. 2018;138:74-80.
    PubMed     Text format     Abstract available


  91. OLIVEIRA A, Rodrigues J, Marques A
    Enhancing our understanding of computerised adventitious respiratory sounds in different COPD phases and healthy people.
    Respir Med. 2018;138:57-63.
    PubMed     Text format     Abstract available


  92. BHATTA L, Leivseth L, Mai XM, Chen Y, et al
    Prevalence and trend of COPD from 1995-1997 to 2006-2008: The HUNT study, Norway.
    Respir Med. 2018;138:50-56.
    PubMed     Text format     Abstract available


  93. BRUSSELLE G, Pavord ID, Landis S, Pascoe S, et al
    Blood eosinophil levels as a biomarker in COPD.
    Respir Med. 2018;138:21-31.
    PubMed     Text format     Abstract available


  94. MORALES DR, Flynn R, Zhang J, Trucco E, et al
    External validation of ADO, DOSE, COTE and CODEX at predicting death in primary care patients with COPD using standard and machine learning approaches.
    Respir Med. 2018;138:150-155.
    PubMed     Text format     Abstract available


  95. NADERI N, Assayag D, Mostafavi-Pour-Manshadi SM, Kaddaha Z, et al
    Long-term azithromycin therapy to reduce acute exacerbations in patients with severe chronic obstructive pulmonary disease.
    Respir Med. 2018;138:129-136.
    PubMed     Text format     Abstract available


  96. CORDOBA-LANUS E, Cabrera-Lopez C, Cazorla-Rivero S, Rodriguez-Perez MC, et al
    Shorter telomeres in non-smoking patients with airflow limitation.
    Respir Med. 2018;138:123-128.
    PubMed     Text format     Abstract available


    April 2018
  97. VAHATALO I, Ilmarinen P, Tuomisto LE, Niemela O, et al
    Inhaled corticosteroids and asthma control in adult-onset asthma: 12-year follow-up study.
    Respir Med. 2018;137:70-76.
    PubMed     Text format     Abstract available


  98. LIN J, Wang W, Chen P, Zhou X, et al
    Prevalence and risk factors of asthma in mainland China: The CARE study.
    Respir Med. 2018;137:48-54.
    PubMed     Text format     Abstract available


  99. SATIRER O, Mete Yesil A, Emiralioglu N, Tugcu GD, et al
    A review of the etiology and clinical presentation of non-cystic fibrosis bronchiectasis: A tertiary care experience.
    Respir Med. 2018;137:35-39.
    PubMed     Text format     Abstract available


  100. THOMSEN AML, Ehrenstein V, Riis AH, Toft G, et al
    The potential impact of paternal age on risk of asthma in childhood: a study within the Danish National Birth Cohort.
    Respir Med. 2018;137:30-34.
    PubMed     Text format     Abstract available


  101. QU Y, Zhang C, Hu Z, Li S, et al
    The 100 most influential publications in asthma from 1960 to 2017: A bibliometric analysis.
    Respir Med. 2018;137:206-212.
    PubMed     Text format     Abstract available


  102. DY T, Lewis EM, Murugan V, Gehlert S, et al
    Caregiver and pediatric provider perspectives on symptom-based inhaled corticosteroid therapy in asthma.
    Respir Med. 2018;137:201-205.
    PubMed     Text format     Abstract available


  103. WACHTEL H, Nagel M, Engel M, El Azzi G, et al
    In vitro and clinical characterization of the valved holding chamber AeroChamber Plus((R)) Flow-Vu((R)) for administrating tiotropium Respimat((R)) in 1-5-year-old children with persistent asthmatic symptoms.
    Respir Med. 2018;137:181-190.
    PubMed     Text format     Abstract available


  104. KURT OK, Ergun D, Basaran N
    Can the ceramic industry be a new and hazardous sector for work-related asthma?
    Respir Med. 2018;137:176-180.
    PubMed     Text format     Abstract available


  105. VAN HIRTUM PV, Sprooten RTM, van Noord JA, van Vliet M, et al
    Long term survival after admission for COPD exacerbation: A comparison with the general population.
    Respir Med. 2018;137:77-82.
    PubMed     Text format     Abstract available


  106. VAZ FRAGOSO CA, Van Ness PH, Murphy TE, McAvay GJ, et al
    Spirometric impairments, cardiovascular outcomes, and noncardiovascular death in older persons.
    Respir Med. 2018;137:40-47.
    PubMed     Text format     Abstract available


  107. LANGTON D, Wang W, Thien F, Plummer V, et al
    The acute effects of bronchial thermoplasty on FEV1.
    Respir Med. 2018;137:147-151.
    PubMed     Text format     Abstract available


  108. ALTER P, Watz H, Kahnert K, Pfeifer M, et al
    Airway obstruction and lung hyperinflation in COPD are linked to an impaired left ventricular diastolic filling.
    Respir Med. 2018;137:14-22.
    PubMed     Text format     Abstract available


  109. CHEROT-KORNOBIS N, Hulo S, Giovannelli J, de Broucker V, et al
    Exhaled breath NOx levels in a middle-aged adults population-based study: reference values and association with the smoking status.
    Respir Med. 2018;137:134-140.
    PubMed     Text format     Abstract available


  110. CHEN YW, Coxson HO, Coupal TM, Lam S, et al
    The contribution of thoracic vertebral deformity and arthropathy to trunk pain in patients with chronic obstructive pulmonary disease (COPD).
    Respir Med. 2018;137:115-122.
    PubMed     Text format     Abstract available


  111. MILNER SC, Boruff JT, Beaurepaire C, Ahmed S, et al
    Rate of, and barriers and enablers to, pulmonary rehabilitation referral in COPD: A systematic scoping review.
    Respir Med. 2018;137:103-114.
    PubMed     Text format     Abstract available


  112. REITER J, Breuer A, Breuer O, Hashavya S, et al
    A quality improvement intervention to reduce emergency department radiography for bronchiolitis.
    Respir Med. 2018;137:1-5.
    PubMed     Text format     Abstract available


    March 2018
  113. BRUMPTON BM, Langhammer A, Henriksen AH, Romundstad PR, et al
    Serum 25-hydroxyvitamin D, vitamin D supplement and asthma control: The HUNT study.
    Respir Med. 2018;136:65-70.
    PubMed     Text format     Abstract available


  114. CIPRANDI G, Schiavetti I, Ricciardolo FLM
    The impact of aging on outpatients with asthma in a real-world setting.
    Respir Med. 2018;136:58-64.
    PubMed     Text format     Abstract available


  115. ZELT JT, Jones JH, Hirai DM, King TJ, et al
    Systemic vascular dysfunction is associated with emphysema burden in mild COPD.
    Respir Med. 2018;136:29-36.
    PubMed     Text format     Abstract available


  116. LISSPERS K, Janson C, Larsson K, Johansson G, et al
    Comorbidity, disease burden and mortality across age groups in a Swedish primary care asthma population: An epidemiological register study (PACEHR).
    Respir Med. 2018;136:15-20.
    PubMed     Text format     Abstract available


  117. SUAREZ-CUARTIN G, Giner J, Merino JL, Rodrigo-Troyano A, et al
    Identification of Pseudomonas aeruginosa and airway bacterial colonization by an electronic nose in bronchiectasis.
    Respir Med. 2018;136:111-117.
    PubMed     Text format     Abstract available


  118. KRIDIN K, Comaneshter D, Batat E, Cohen AD, et al
    COPD and lung cancer in patients with pemphigus- a population based study.
    Respir Med. 2018;136:93-97.
    PubMed     Text format     Abstract available


  119. MIRAVITLLES M, Sliwinski P, Rhee CK, Costello RW, et al
    Evaluation of criteria for clinical control in a prospective, international, multicenter study of patients with COPD.
    Respir Med. 2018;136:8-14.
    PubMed     Text format     Abstract available


  120. EPSTEIN D, Nasser R, Mashiach T, Azzam ZS, et al
    Increased red cell distribution width: A novel predictor of adverse outcome in patients hospitalized due to acute exacerbation of chronic obstructive pulmonary disease.
    Respir Med. 2018;136:1-7.
    PubMed     Text format     Abstract available


    February 2018
  121. GOULD CF, Perzanowski MS, Evans D, Bruzzese JM, et al
    Association of exercise-induced wheeze and other asthma symptoms with emergency department visits and hospitalizations in a large cohort of urban adolescents.
    Respir Med. 2018;135:42-50.
    PubMed     Text format     Abstract available


  122. MARTINEZ-RIVERA C, Crespo A, Pinedo-Sierra C, Garcia-Rivero JL, et al
    Mucus hypersecretion in asthma is associated with rhinosinusitis, polyps and exacerbations.
    Respir Med. 2018;135:22-28.
    PubMed     Text format     Abstract available


  123. VARGAS MH, Becerril-Angeles M, Medina-Reyes IS, Rascon-Pacheco RA, et al
    Altitude above 1500m is a major determinant of asthma incidence. An ecological study.
    Respir Med. 2018;135:1-7.
    PubMed     Text format     Abstract available


  124. RODRIGUEZ-JIMENEZ JC, Moreno-Paz FJ, Teran LM, Guani-Guerra E, et al
    Aspirin exacerbated respiratory disease: Current topics and trends.
    Respir Med. 2018;135:62-75.
    PubMed     Text format     Abstract available


  125. SIKJAER MG, Lokke A, Hilberg O
    The influence of psychiatric disorders on the course of lung cancer, chronic obstructive pulmonary disease and tuberculosis.
    Respir Med. 2018;135:35-41.
    PubMed     Text format     Abstract available


  126. KAFAEI SHIRMANESH Y, Jones MD
    Physical ability of people with rheumatoid arthritis and age-sex matched controls to use four commonly prescribed inhaler devices.
    Respir Med. 2018;135:12-14.
    PubMed     Text format     Abstract available


    January 2018
  127. SUZUKAWA M, Matsumoto H, Ohshima N, Tashimo H, et al
    Baseline serum CXCL10 and IL-12 levels may predict severe asthmatics' responsiveness to omalizumab.
    Respir Med. 2018;134:95-102.
    PubMed     Text format     Abstract available


  128. KORENBLAT P, Kerwin E, Leshchenko I, Yen K, et al
    Efficacy and safety of lebrikizumab in adult patients with mild-to-moderate asthma not receiving inhaled corticosteroids.
    Respir Med. 2018;134:143-149.
    PubMed     Text format     Abstract available


  129. HAUGHNEY J, Morice A, Blyth KG, Lee AJ, et al
    A retrospective cohort study in severe asthma describing commonly measured biomarkers: Eosinophil count and IgE levels.
    Respir Med. 2018;134:117-123.
    PubMed     Text format     Abstract available


  130. GAO YH, Liu SX, Cui JJ, Wang LY, et al
    Subclinical atherosclerosis in adults with steady-state bronchiectasis: A case-control study.
    Respir Med. 2018;134:110-116.
    PubMed     Text format     Abstract available


  131. KAHNERT K, Alter P, Young D, Lucke T, et al
    The revised GOLD 2017 COPD categorization in relation to comorbidities.
    Respir Med. 2018;134:79-85.
    PubMed     Text format     Abstract available


  132. MIRAVITLLES M, Menezes A, Lopez Varela MV, Casas A, et al
    Prevalence and impact of respiratory symptoms in a population of patients with COPD in Latin America: The LASSYC observational study.
    Respir Med. 2018;134:62-69.
    PubMed     Text format     Abstract available


  133. FERGUSON GT, Hickey AJ, Dwivedi S
    Co-suspension delivery technology in pressurized metered-dose inhalers for multi-drug dosing in the treatment of respiratory diseases.
    Respir Med. 2018;134:16-23.
    PubMed     Text format     Abstract available


  134. DE BLASIO F, Di Gregorio A, de Blasio F, Bianco A, et al
    Malnutrition and sarcopenia assessment in patients with chronic obstructive pulmonary disease according to international diagnostic criteria, and evaluation of raw BIA variables.
    Respir Med. 2018;134:1-5.
    PubMed     Text format     Abstract available


    December 2017
  135. VILMANN L, Buchvald F, Green K, Nielsen KG, et al
    Fractional exhaled nitric oxide and multiple breath nitrogen washout in preschool healthy and asthmatic children.
    Respir Med. 2017;133:42-47.
    PubMed     Text format     Abstract available


  136. NICHOLSON A, Pollard SL, Lima JJ, Romero KM, et al
    Serum folate concentrations, asthma, atopy, and asthma control in Peruvian children.
    Respir Med. 2017;133:29-35.
    PubMed     Text format     Abstract available


  137. LAWSON JA, Brozek G, Shpakou A, Fedortsiv O, et al
    An international comparison of asthma, wheeze, and breathing medication use among children.
    Respir Med. 2017;133:22-28.
    PubMed     Text format     Abstract available


  138. SZENTPETERY SS, Gruzieva O, Forno E, Han YY, et al
    Combined effects of multiple risk factors on asthma in school-aged children.
    Respir Med. 2017;133:16-21.
    PubMed     Text format     Abstract available


    November 2017
  139. JUDSON MA
    Endpoints in sarcoidosis: More like IPF or asthma?
    Respir Med. 2017 Nov 20. pii: S0954-6111(17)30384.
    PubMed     Text format    


  140. SVEDSATER H, Leather D, Robinson T, Doll H, et al
    Evaluation and quantification of treatment preferences for patients with asthma or COPD using discrete choice experiment surveys.
    Respir Med. 2017;132:76-83.
    PubMed     Text format     Abstract available


  141. CONDREAY L, Chiano M, Ortega H, Buchan N, et al
    No genetic association detected with mepolizumab efficacy in severe asthma.
    Respir Med. 2017;132:178-180.
    PubMed     Text format     Abstract available


  142. SUNDH J, Wireklint P, Hasselgren M, Montgomery S, et al
    Health-related quality of life in asthma patients - A comparison of two cohorts from 2005 and 2015.
    Respir Med. 2017;132:154-160.
    PubMed     Text format     Abstract available


  143. LEE J, Kronborg C, O'Hehir RE, Hew M, et al
    Who's at risk of thunderstorm asthma? The ryegrass pollen trifecta and lessons learnt from the Melbourne thunderstorm epidemic.
    Respir Med. 2017;132:146-148.
    PubMed     Text format     Abstract available


  144. PENG YH, Su SY, Liao WC, Huang CW, et al
    Asthma is associated with endometriosis: A retrospective population-based cohort study.
    Respir Med. 2017;132:112-116.
    PubMed     Text format     Abstract available


  145. BLAIS CM, Davis BE, Cockcroft DW
    Diversity of methacholine dose-response curves among asymptomatic non-asthmatics.
    Respir Med. 2017;132:109-111.
    PubMed     Text format    


  146. MAZENQ J, Dubus JC, Gaudart J, Charpin D, et al
    City housing atmospheric pollutant impact on emergency visit for asthma: A classification and regression tree approach.
    Respir Med. 2017;132:1-8.
    PubMed     Text format     Abstract available


    October 2017
  147. BAKIRTAS A, Kutlu A, Baccioglu A, Erkekol FO, et al
    Physicians' preference for controller medication in mild persistent asthma.
    Respir Med. 2017;131:236-240.
    PubMed     Text format     Abstract available


  148. LI N, Qiu R, Yang Z, Li J, et al
    Sputum microbiota in severe asthma patients: Relationship to eosinophilic inflammation.
    Respir Med. 2017;131:192-198.
    PubMed     Text format     Abstract available


  149. SCHMIDT O, Petro W, Hoheisel G, Kanniess F, et al
    Real-life effectiveness of asthma treatment with a fixed-dose fluticasone/formoterol pressurised metered-dose inhaler - Results from a non-interventional study.
    Respir Med. 2017;131:166-174.
    PubMed     Text format     Abstract available


  150. AGGELOU K, Siafakas N
    Medical lung volume reduction for severe emphysema: A review.
    Respir Med. 2017;131:141-147.
    PubMed     Text format     Abstract available


  151. FITZGERALD JM, Tavakoli H, Lynd LD, Al Efraij K, et al
    The impact of inappropriate use of short acting beta agonists in asthma.
    Respir Med. 2017;131:135-140.
    PubMed     Text format     Abstract available


  152. ZIERAU L, Walsted ES, Thomsen SF, Backer V, et al
    Response to omalizumab in patients with severe allergic asthma: A real-life study.
    Respir Med. 2017;131:109-113.
    PubMed     Text format     Abstract available


    September 2017
  153. TALINI D, Ciberti A, Bartoli D, Del Guerra P, et al
    Work-related asthma in a sample of subjects with established asthma.
    Respir Med. 2017;130:85-91.
    PubMed     Text format     Abstract available


  154. MANISCALCO M, Zamparelli AS, Vitale DF, Faraone S, et al
    Long-term effect of weight loss induced by bariatric surgery on asthma control and health related quality of life in asthmatic patients with severe obesity: A pilot study.
    Respir Med. 2017;130:69-74.
    PubMed     Text format     Abstract available


  155. DI BONA D, Fiorino I, Taurino M, Frisenda F, et al
    Long-term "real-life" safety of omalizumab in patients with severe uncontrolled asthma: A nine-year study.
    Respir Med. 2017;130:55-60.
    PubMed     Text format     Abstract available


  156. COX CA, Boudewijn IM, Vroegop SJ, Schokker S, et al
    Extrafine compared to non-extrafine particle inhaled corticosteroids in smokers and ex-smokers with asthma.
    Respir Med. 2017;130:35-42.
    PubMed     Text format     Abstract available


  157. TANNO LK, Haahtela T, Calderon MA, Cruz A, et al
    Implementation gaps for asthma prevention and control.
    Respir Med. 2017;130:13-19.
    PubMed     Text format     Abstract available


    June 2017
  158. DI MARCO F, Terraneo S, Job S, Rinaldo RF, et al
    Cardiopulmonary exercise testing and second-line pulmonary function tests to detect obstructive pattern in symptomatic smokers with borderline spirometry.
    Respir Med. 2017;127:7-13.
    PubMed     Text format     Abstract available


  159. LIN J, Li J, Yu W, Liu Y, et al
    A multicenter, cross-sectional, observational study of budesonide/formoterol maintenance and reliever therapy in real-world settings.
    Respir Med. 2017;127:45-50.
    PubMed     Text format     Abstract available


  160. MACEDO P, Zhang Q, Saito J, Liang Z, et al
    Analysis of bronchial biopsies in chronic cough.
    Respir Med. 2017;127:40-44.
    PubMed     Text format     Abstract available


  161. KONNO S, Makita H, Suzuki M, Shimizu K, et al
    Acute bronchodilator responses to beta2-agonist and anticholinergic agent in COPD: Their different associations with exacerbation.
    Respir Med. 2017;127:14-20.
    PubMed     Text format     Abstract available


    May 2017
  162. GLOECKL R, Jarosch I, Bengsch U, Claus M, et al
    What's the secret behind the benefits of whole-body vibration training in patients with COPD? A randomized, controlled trial.
    Respir Med. 2017;126:17-24.
    PubMed     Text format     Abstract available


  163. MESQUITA R, Meijer K, Pitta F, Azcuna H, et al
    Changes in physical activity and sedentary behaviour following pulmonary rehabilitation in patients with COPD.
    Respir Med. 2017;126:122-129.
    PubMed     Text format     Abstract available


  164. HANANIA NA, Tashkin DP, Kerwin EM, Donohue JF, et al
    Long-term safety and efficacy of glycopyrrolate/formoterol metered dose inhaler using novel Co-Suspension Delivery Technology in patients with chronic obstructive pulmonary disease.
    Respir Med. 2017;126:105-115.
    PubMed     Text format     Abstract available


    April 2017
  165. HAYES D JR, Tumin D, Budev MM, Tobias JD, et al
    Adverse outcomes associated with pulmonary hypertension in chronic obstructive pulmonary disease after bilateral lung transplantation.
    Respir Med. 2017 Apr 22. pii: S0954-6111(17)30127.
    PubMed     Text format     Abstract available


  166. BODINI R, Santus P, Di Marco F, Aliberti S, et al
    Epidemiology of clinical trials of medicines in respiratory diseases in Europe and Italy.
    Respir Med. 2017;125:8-11.
    PubMed     Text format     Abstract available


  167. DI MARCO F, Santus P, Scichilone N, Solidoro P, et al
    Symptom variability and control in COPD: Advantages of dual bronchodilation therapy.
    Respir Med. 2017;125:49-56.
    PubMed     Text format     Abstract available


  168. D'URZO A, Rennard S, Kerwin E, Donohue JF, et al
    A randomised double-blind, placebo-controlled, long-term extension study of the efficacy, safety and tolerability of fixed-dose combinations of aclidinium/formoterol or monotherapy in the treatment of chronic obstructive pulmonary disease.
    Respir Med. 2017;125:39-48.
    PubMed     Text format     Abstract available


  169. SHIH YN, Chen YT, Chu H, Shih CJ, et al
    Association of pre-hospital theophylline use and mortality in chronic obstructive pulmonary disease patients with sepsis.
    Respir Med. 2017;125:33-38.
    PubMed     Text format     Abstract available


  170. TOTTENBORG SS, Lange P, Thomsen RW, Nielsen H, et al
    Reducing socioeconomic inequalities in COPD care in the hospital outpatient setting - A nationwide initiative.
    Respir Med. 2017;125:19-23.
    PubMed     Text format     Abstract available


  171. HONG JY, Jung JY, Lee MG, Kim SK, et al
    Changes in the prevalence of COPD in Korea between 2001 and 2011 in the KNHANES data.
    Respir Med. 2017;125:12-18.
    PubMed     Text format     Abstract available


    March 2017
  172. ROGLIANI P, Calzetta L, Coppola A, Cavalli F, et al
    Optimizing drug delivery in COPD: The role of inhaler devices.
    Respir Med. 2017;124:6-14.
    PubMed     Text format     Abstract available


  173. KARDOS P, Vogelmeier C, Worth H, Buhl R, et al
    A two-year evaluation of the 'real life' impact of COPD on patients in Germany: The DACCORD observational study.
    Respir Med. 2017;124:57-64.
    PubMed     Text format     Abstract available


    February 2017
  174. BOURBEAU J, Aaron SD, Barnes NC, Davis KJ, et al
    Evaluating the risk of pneumonia with inhaled corticosteroids in COPD: Retrospective database studies have their limitations SA.
    Respir Med. 2017;123:94-97.
    PubMed     Text format     Abstract available


  175. PELKONEN MK, Notkola IK, Laatikainen TK, Jousilahti P, et al
    Chronic bronchitis in relation to hospitalization and mortality over three decades.
    Respir Med. 2017;123:87-93.
    PubMed     Text format     Abstract available


  176. SILER TM, Nagai A, Scott-Wilson CA, Midwinter DA, et al
    A randomised, phase III trial of once-daily fluticasone furoate/vilanterol 100/25 mug versus once-daily vilanterol 25 mug to evaluate the contribution on lung function of fluticasone furoate in the combination in patients with COPD.
    Respir Med. 2017;123:8-17.
    PubMed     Text format     Abstract available


  177. OYAMA Y, Enomoto N, Suzuki Y, Kono M, et al
    Evaluation of urinary desmosines as a noninvasive diagnostic biomarker in patients with idiopathic pleuroparenchymal fibroelastosis (PPFE).
    Respir Med. 2017;123:63-70.
    PubMed     Text format     Abstract available


  178. POMPE E, Galban CJ, Ross BD, Koenderman L, et al
    Parametric response mapping on chest computed tomography associates with clinical and functional parameters in chronic obstructive pulmonary disease.
    Respir Med. 2017;123:48-55.
    PubMed     Text format     Abstract available


  179. WANG LY, Zhu YN, Cui JJ, Yin KQ, et al
    Subclinical atherosclerosis risk markers in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis.
    Respir Med. 2017;123:18-27.
    PubMed     Text format     Abstract available


  180. MELZER AC, Ghassemieh BJ, Gillespie SE, Lindenauer PK, et al
    Patient characteristics associated with poor inhaler technique among a cohort of patients with COPD.
    Respir Med. 2017;123:124-130.
    PubMed     Text format     Abstract available


  181. DELLWEG D, Reissig K, Hoehn E, Siemon K, et al
    Inspiratory muscle training during rehabilitation in successfully weaned hypercapnic patients with COPD.
    Respir Med. 2017;123:116-123.
    PubMed     Text format     Abstract available


    January 2017
  182. BUHL R, Magder S, Bothner U, Tetzlaff K, et al
    Long-term general and cardiovascular safety of tiotropium/olodaterol in patients with moderate to very severe chronic obstructive pulmonary disease.
    Respir Med. 2017;122:58-66.
    PubMed     Text format     Abstract available


  183. LI JX, Fan LC, Li MH, Cao WJ, et al
    Beneficial effects of Omalizumab therapy in allergic bronchopulmonary aspergillosis: A synthesis review of published literature.
    Respir Med. 2017;122:33-42.
    PubMed     Text format     Abstract available


  184. PAULIN FV, Zagatto AM, Chiappa GR, Muller PT, et al
    Addition of vitamin B12 to exercise training improves cycle ergometer endurance in advanced COPD patients: A randomized and controlled study.
    Respir Med. 2017;122:23-29.
    PubMed     Text format     Abstract available


  185. MUELLER S, Wilke T, Bechtel B, Punekar YS, et al
    Non-persistence and non-adherence to long-acting COPD medication therapy: A retrospective cohort study based on a large German claims dataset.
    Respir Med. 2017;122:1-11.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: